Works cited by this work

8 works

Work: IMMUNOTHERAPEUTIC SIGNIFICANCE OF NTPASE 8 IN ONCOLOGY

1. The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets

   Bertrand Allard, Maria Serena Longhi, Simon C. Robson +1

   Review article20172 citations

   ABIABI:AkademIndex/openalex/2026.other.020474

2. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

   Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider +26

   Article20182 citations

   ABIABI:AkademIndex/openalex/2026.other.769170

3. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769168

4. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769169

5. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769171

6. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769172

7. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769173

8. Untitled

   Other1 citations

   ABIABI:AkademIndex/openalex/2026.other.769174